Previous research has shown that 4% to 25% of melanoma patients have heterogeneous BRAFV600E genotype between their tumors depending on the type of metastasis.25,26 Our study contained 2 (7%) patients with discordant BRAF mutation status between paired tumors. The gene discussed is BRAF; the disease is melanoma.